West Syndrome Market Outlook:
West Syndrome Market size was valued at USD 479.5 million in 2025 and is likely to cross USD 796.06 million by 2035, expanding at more than 5.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of west syndrome is assessed at USD 501.94 million.
The growth of the market can be attributed to the rising prevalence of epilepsy. The World Health Organization (WHO) provided a report stating that nearly 5 million individuals are diagnosed with epilepsy every year worldwide. Epilepsy is one of the most common chronic disorders across the world. It is a non-communicable disease that affects the central nervous system and causes physical impairment of the body. The recurrent seizures cause discomfort in movement eventually leading to paralysis. It is mainly caused by brain damage, head injury, absence of oxygen, brain infection, brain tumor, meningitis, encephalitis, and neurocysticercosis.
Global west syndrome market trends such as growing awareness of west syndrome in the global population and rising healthcare expenditure are projected to influence the growth of the market positively over the forecast period. In a report published by the World Bank, it was stated that in 2019, the healthcare expenditure reached 1,121.9 per capita. West syndrome is a serious medical condition with a drastically irregular pattern of brain waves which is also known as hypsarrhythmia. West syndrome also includes features such as infantile spasms and loss of developmental milestones. Moreover, spiking R&D spending on neurological illnesses and the rising inclination of the global population toward novel therapies are further anticipated to propel the growth of the market over the forecast period.
